|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Predictive Factors of Efficacy
of the Somatostatin Analogue Octreotide as First Line Therapy
for Advanced Pancreatic Endocrine Carcinoma Endocr Relat Cancer. 2006 Dec;13(4):1213-21.
PMID: 17158766 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |